FDA Webview
X
about-us-banner

Articles

Home /Articles / FDA Federal Register Notices

Comments Sought on Global Task Force Device Documents

08/23/2004

Federal Register Notice: FDA is making available two proposed documents that have been prepared by Study Groups 1 and 2 of the Glo...

Changes to Psychopharm/Pediatric Panel Meeting Notice

08/23/2004

Federal Register Notice: FDA is amending the notice of the joint meeting of the 9/13-14 Psychopharmacologic Drugs Advisory Committ...

Corrections Made to FDA MOU Notice

08/23/2004

Federal Register Correction: FDA makes small corrections in an 8/2 notice on the Memorandum of Understanding Between the Food and ...

Special Control Set for Metal Alloy Devices

08/23/2004

Federal Register Final rule: FDA is amending the identification and classification regulations of gold-based alloys and precious m...

Comments Sought on Device Third-Party Review

08/10/2004

Federal Register Notice: FDA is seeking public comment on information collection requirements for medical device third-party revie...

Panel to Discuss AZ’s Exanta

08/10/2004

Federal Register Notice: FDA’s Cardiovascular and Renal Drugs Advisory Committee will be held 9/10, from 8:30 a.m. to 5 p.m....

FDA OKs Pfizer’s NADA for Parasite Treatment

08/10/2004

Federal Register Final rule: FDA is amending the animal drug regulations to reflect approval of a supplemental NADA filed by Pfize...

Panel to Discuss Weight-Control Drug Guidance

08/06/2004

Federal Register Notice: FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will meet 9/8 at the Holiday Inn, Bethe...

Brevibloc and Toradol Not Withdrawn for S&E

08/04/2004

Federal Register Notice: FDA has determined that the two drug products Baxter Healthcare’s Brevibloc (esmolol HCl) injection...

Comments Sought on ADHD Protocol

08/04/2004

Federal Register Notice: The Office for Human Research Protections, Office of Public Health and Science, Department of Health and ...